Current Report · Items 7.01, 9.01 · 8-K
CNS Pharmaceuticals, Inc.
CNSPNASDAQEQUITYCurrent
Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On July 2, 2026, CNS Pharmaceuticals, Inc. (the “Company”) posted the investor presentation set forth in Exhibit 99.1 on its website. The information contained in Item 7.01 of this Current Report on Form 8-K is being furnished and shall not be “filed” for the purpose of the Securities Exchange Act of 1934, as amended (“Exchange Act”), nor shall it be incorporat…
Disclosure sections
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure.
On
July 2, 2026, CNS Pharmaceuticals, Inc. (the “Company”) posted the investor presentation set forth in Exhibit 99.1 on its
website.
The
information contained in Item 7.01 of this Current Report on Form 8-K is being furnished and shall not be “filed” for the
purpose of the Securities Exchange Act of 1934, as amended (“Exchange Act”), nor shall it be incorporated by reference in
any filing under the Exchange Act or the Securities Act of 1933, as amended (“Securities Act”), unless specifically identified
therein as being incorporated by reference.